154 related articles for article (PubMed ID: 33068486)
1. Development of an immunocompetent mouse model susceptible to Cryptosporidium tyzzeri infection.
Huang Y; Song Y; You Y; Mi R; Han X; Gong H; Chen Z; Liu Y
Parasite Immunol; 2021 Jan; 43(1):e12800. PubMed ID: 33068486
[TBL] [Abstract][Full Text] [Related]
2. Induction of immune responses in mice by a DNA vaccine encoding Cryptosporidium parvum Cp12 and Cp21 and its effect against homologous oocyst challenge.
Yu Q; Li J; Zhang X; Gong P; Zhang G; Li S; Wang H
Vet Parasitol; 2010 Aug; 172(1-2):1-7. PubMed ID: 20541869
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of recombinant Cryptosporidium parvum CpPRP1 sushi domain against C. tyzzeri infection in mice.
Huang Y; Cao W; Shi K; Mi R; Lu K; Han X; Chen Z
Parasite Immunol; 2017 Sep; 39(9):. PubMed ID: 28599077
[TBL] [Abstract][Full Text] [Related]
4. Application of recombinant Cryptosporidium parvum P23 for isolation and prevention.
Omidian Z; Ebrahimzadeh E; Shahbazi P; Asghari Z; Shayan P
Parasitol Res; 2014 Jan; 113(1):229-37. PubMed ID: 24154594
[TBL] [Abstract][Full Text] [Related]
5. Multivalent DNA vaccine induces protective immune responses and enhanced resistance against Cryptosporidium parvum infection.
Wang C; Luo J; Amer S; Guo Y; Hu Y; Lu Y; Wang H; Duan M; He H
Vaccine; 2010 Dec; 29(2):323-8. PubMed ID: 21029808
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis.
Benitez A; Priest JW; Ehigiator HN; McNair N; Mead JR
Vaccine; 2011 Nov; 29(49):9239-45. PubMed ID: 21968447
[TBL] [Abstract][Full Text] [Related]
7. A recombinant DNA vaccine encoding C. andersoni oocyst wall protein induces immunity against experimental C. parvum infection.
Zheng J; Ren W; Pan Q; Wang Q; Elhag IA; Li J; Li M; Gong P; Liu Y; Zhang X
Vet Parasitol; 2011 Jun; 179(1-3):7-13. PubMed ID: 21450406
[TBL] [Abstract][Full Text] [Related]
8. Induction of murine immune responses by DNA encoding a 23-kDa antigen of Cryptosporidium parvum.
Ehigiator HN; Romagnoli P; Priest JW; Secor WE; Mead JR
Parasitol Res; 2007 Sep; 101(4):943-50. PubMed ID: 17487508
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of recombinant P23 protein as a vaccine for passive immunization of newborn calves against Cryptosporidium parvum.
Askari N; Shayan P; Mokhber-Dezfouli MR; Ebrahimzadeh E; Lotfollahzadeh S; Rostami A; Amininia N; Ragh MJ
Parasite Immunol; 2016 May; 38(5):282-9. PubMed ID: 27012710
[TBL] [Abstract][Full Text] [Related]
10. Isolation and identification of sporozoite membrane protein of Cryptosporidium parvum and evaluation of calmodulin-like protein immune protection.
Huang Y; Chen Y; Liu Y; Mi R; Han X; Gong H; Cheng L; Chen Z
Parasite Immunol; 2022 Aug; 44(8):e12937. PubMed ID: 35652261
[TBL] [Abstract][Full Text] [Related]
11. Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.
Enriquez FJ; Riggs MW
Infect Immun; 1998 Sep; 66(9):4469-73. PubMed ID: 9712802
[TBL] [Abstract][Full Text] [Related]
12. Attempts to immunize chickens against Cryptosporidium baileyi with C. parvum oocysts and Paracox vaccine.
Sréter T; Hornok S; Varga I; Békési L; Széll Z
Folia Parasitol (Praha); 1997; 44(1):77-80. PubMed ID: 9188177
[TBL] [Abstract][Full Text] [Related]
13. Response of T lymphocytes from previously infected calves to recombinant Cryptosporidium parvum P23 vaccine antigen.
Wyatt CR; Lindahl S; Austin K; Kapil S; Branch J
J Parasitol; 2005 Oct; 91(5):1239-42. PubMed ID: 16419781
[TBL] [Abstract][Full Text] [Related]
14. A productive immunocompetent mouse model of cryptosporidiosis with long oocyst shedding duration for immunological studies.
He X; Huang W; Sun L; Hou T; Wan Z; Li N; Guo Y; Kváč M; Xiao L; Feng Y
J Infect; 2022 May; 84(5):710-721. PubMed ID: 35192895
[TBL] [Abstract][Full Text] [Related]
15. Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein.
Perryman LE; Kapil SJ; Jones ML; Hunt EL
Vaccine; 1999 Apr; 17(17):2142-9. PubMed ID: 10367947
[TBL] [Abstract][Full Text] [Related]
16. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity.
Ungar BL; Kao TC; Burris JA; Finkelman FD
J Immunol; 1991 Aug; 147(3):1014-22. PubMed ID: 1677668
[TBL] [Abstract][Full Text] [Related]
17. Cryptosporidium Priming Is More Effective than Vaccine for Protection against Cryptosporidiosis in a Murine Protein Malnutrition Model.
Bartelt LA; Bolick DT; Kolling GL; Roche JK; Zaenker EI; Lara AM; Noronha FJ; Cowardin CA; Moore JH; Turner JR; Warren CA; Buck GA; Guerrant RL
PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004820. PubMed ID: 27467505
[TBL] [Abstract][Full Text] [Related]
18. Development of Two Mouse Models for Vaccine Evaluation against Cryptosporidiosis.
Dayao DA; Jaskiewcz J; Lee S; Oliveira BC; Sheoran A; Widmer G; Tzipori S
Infect Immun; 2022 Jul; 90(7):e0012722. PubMed ID: 35735982
[TBL] [Abstract][Full Text] [Related]
19. Expression of P23 of Cryptosporidium parvum in Toxoplasma gondii and evaluation of its protective effects.
Shirafuji H; Xuan X; Kimata I; Takashima Y; Fukumoto S; Otsuka H; Nagasawa H; Suzuki H
J Parasitol; 2005 Apr; 91(2):476-9. PubMed ID: 15986633
[TBL] [Abstract][Full Text] [Related]
20. Selection and identification of a new adhesion protein of Cryptosporidium parvum from a cDNA library by ribosome display.
Xiao D; Yin C; Zhang Q; Li JH; Gong PT; Li SH; Zhang GC; Gao YJ; Zhang XC
Exp Parasitol; 2011 Oct; 129(2):183-9. PubMed ID: 21740903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
